# HRQOL in Prostate Cancer Patients Treated With Radiotherapy

> **NCT05645237** · — · ACTIVE_NOT_RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 600 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT05645237
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-04-08
- **Primary completion:** 2027-06-01
- **Final completion:** 2030-06-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05645237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05645237, "HRQOL in Prostate Cancer Patients Treated With Radiotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05645237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*